The second messenger cAMP stimulates the expression of numerous genes via the protein kinase A-mediated phosphorylation of the . Although phosphorylation may stimulate transcription factors by inducing their nuclear targeting or DNA-binding activities (2), CREB belongs to a group of signal-dependent activators whose trans-activation potential is specifically affected (3). Phosphorylation at Ser-133 appears to induce CREB activity by promoting its association with the phospho-CREB-binding protein (CBP) (4). This hypothesis is supported by studies in which microinjection of anti-CBP antiserum could block transcription from a cAMP-responsive promoter and by transfection studies where overexpression of CBP could potentiate CREB activity in a phosphorylation-dependent manner (5, 6).
METHODS
Western Blot and Two-Dimensional Tryptic Mapping. Western blot analysis and two-dimensional tryptic mapping studies were performed on Jurkat whole-cell extracts as described (9, 10) . P-CREB levels in whole-cell extracts were analyzed with P-CREB-specific antiserum 5322 (10) . CREB antiserum 253 was prepared by injecting rabbits with purified recombinant CREB protein (amino acids 1-341). Total CREB levels were measured with nondiscriminating CREB antiserum 220. Immunoreactive complexes were detected with 125I-labeled protein A. CBP antiserum (5614) was prepared by injecting rabbits with recombinant CBP polypeptide (amino acids 440-660).
Plasmids and Transfections. CREB, GAL4-CREB, GAL-KID, and CRE-CAT plasmids have been described (3, 9, 11) . Protein kinase C (PKC) expression vector pCDM8 PKC7 (12) was a generous gift of E. Olson. CBP2 expression plasmid was constructed by inserting a mouse CBP cDNA fragment encoding amino acids 1-737 into a human cytomegalovirus (CMV) expression vector. This fragment of CBP contains the nuclear localizing sequence located at amino acids 20-30 (13) . CBP2-VP16 expression vector was constructed by inserting the viral protein 16 (VP16) activation domain-in-frame into the CMV-CBP2 effector plasmid above. All transient assays represent results from at least three independent experiments. Assays were normalized to (-galactosidase or luciferase activity derived from cotransfected Rous sarcoma virus (RSV)-p-galactosidase or RSV-luciferase control plasmid.
RESULTS
Previous reports demonstrating that the calcium second messenger pathway stimulates the c-fos gene via CREB phosphorylation (14) prompted us to examine whether triggering the T-cell receptor (TCR), an event that leads to increased intracellular calcium (15) , might correspondingly induce CREB activity in Jurkat T cells. Activation of the TCR-CD3 complex by OKT3, a mouse monoclonal antibody that recognizes the CD3 component of the TCR, stimulated phosphorylation of CREB at Ser-133 ( Fig. 1A) To determine whether TCR activation could induce cAMP response element (CRE)-dependent gene expression as predicted from its effects on CREB phosphorylation, we performed transient transfection assays in Jurkat cells (Fig. 2) . Forskolin (10 ,M) treatment induced a somatostatin CRE-CAT reporter about 10-fold in Jurkat cells, but OKT3 had no effect on reporter activity ( Fig. 2A Upper) Fig. 2A Lower) . A phosphorylation-deficient GAL-CREB Ml mutant (Ser-133 to Ala-133) was refractory to cAMP induction, demonstrating that Jurkat cells are indeed capable of supporting PKA-mediated activation of CREB via Ser-133. In keeping with its observed effects on CRE reporter expression, however, OKT3 had no effect on GAL-CREB activity in Jurkat cells ( Fig. 2A Lower) .
To test if PKA could overcome a negative event or provide a second positive event that was necessary for target gene activation, we titrated forskolin with a constant amount of OKT3. When combined with a suboptimal dose of forskolin (3 ,uM), OKT3 could induce CRE-dependent promoter activity (data not shown) as well as GAL4-CREB-responsive transcription in transfected cells (Fig. 2B) . At these concentrations (3 ,tM), forskolin did not appreciably augment TCR-induced phosphorylation of CREB (Fig. 2C) , suggesting that cAMP may regulate a second protein that is important for transactivation through CREB.
Previous work showing that the phospho-CREB binding protein CBP is required for transcriptional induction in response to cAMP (5) prompted us to examine whether CREB-CBP complex formation could be induced by forskolin but not by OKT3 in Jurkat cells. To visualize such complexes, we employed a CREB antiserum (253) that was raised against the full-length recombinant CREB protein. In reconstitution assays using recombinant CBP and CREB, antiserum 253 could indeed coprecipitate CBP and phosphorylated but not unphosphorylated CREB (Fig. 3A) .
Immunoprecipitates prepared with CREB antiserum 253 under nondenaturing conditions contained comparable levels of CREB protein in samples from control, forskolin, or OKT3-treated Jurkat nuclear lysates (Fig. 3B Left) . To evaluate CBP content in these precipitates, we disrupted immune complexes with SDS buffer, and after dilution into RIPA buffer, we incubated them with anti-CBP antiserum plus protein A-Sepharose. SDS/PAGE analysis of these immunoprecipitates revealed negligible levels of CBP from control or OKT3-treated nuclear lysates (Fig. 3B Center) , but immune complexes prepared from forskolin and forskolinplus OKT3-treated samples contained 5-to 10-fold higher levels of CBP. Total levels of CBP did not differ appreciably between the various lysates (Fig. 3B Right) , suggesting that forskolin but not OKT3 induced formation of CREB-CBP complexes in Jurkat cells.
We have previously observed that the interaction between CREB and CBP is confined to short domains in each protein: in CREB, a-60-amino-acid kinase-inducible domain (KID), which, upon phosphorylation at Ser-133, binds to a 126-amino-acid P-CREB-binding domain (amino acids 553-679) in CBP. To confirm results from coprecipitation studies and to test whether interaction between these domains is dependent on PKA in vivo, we employed a mammalian two-hybrid assay (Fig. 4) (17) . Although PKA-deficient PC-12 cell lines retain the capacity to stimulate CREB phosphorylation in response to membrane depolarization, they are unable to induce c-fos expression. Our results extend these observations by demonstrating that lowlevel stimulation of PKA is permissive for CREB activation through such non-PKA-mediated pathways. Given the low level of PKA activity that appears to be required for transcriptional induction by these pathways, the high basal PKA activity in REF52 cells may explain why microinjection of P-CREB protein is sufficient to stimulate target gene expression without concomitant stimulation by cAMP (7) .
In addition to its role in transcriptional responses to cAMP, CBP appears to mediate transcriptional induction through mitogenic pathways such as serum and phorbol esters (5) . The presence of a common mediator for such disparate signaling pathways suggests the potential for transcriptional interference should CBP levels be limiting. Indeed a significant fraction of CBP (10-20%) appears to associate with P-CREB after induction by cAMP. The requirement for a second PKAregulated event may safeguard against interference between signaling pathways by preventing CBP recruitment to CREB under conditions (such as TCR induction) where CBP is required for other signal-dependent activators.
